Ngā hua rapu - He, Lijie
- E whakaatu ana i te 1 - 20 hua o te 28
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
-
6
-
7
The Association Between Serum Complement 4 and Kidney Disease Progression in Idiopathic Membranous Nephropathy: A Multicenter Retrospective Cohort Study mā Liu, Jing, Zha, Yang, Zhang, Peng, He, Peng, He, Lijie
I whakaputaina 2022Text -
8
Clinical value of Pro-GRP and T lymphocyte subpopulation for the assessment of immune functions of lung cancer patients after DC-CIK biological therapy mā He, Lijie, Wang, Jing, Chang, Dandan, Lv, Dandan, Li, Haina, Zhang, Heping
I whakaputaina 2018Text -
9
-
10
Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report mā Ma, Yi, He, Lijie, Huang, Qianwen, Zheng, Shuang, Zhang, Zhiqiang, Li, Hongshi, Liu, Shuang
I whakaputaina 2018Text -
11
-
12
Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis mā Liu, An, Song, Qiong, Zheng, Yong, Xu, Guoshuang, Huang, Chen, Sun, Shiren, He, Lijie, Zhao, Lijuan, Zhou, Meilan
I whakaputaina 2019Text -
13
The T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression mā Sun, Shiren, Sun, Wenjuan, Xia, Lin, Liu, Limin, Du, Rui, He, Lijie, Li, Rong, Wang, Hanmin, Huang, Chen
I whakaputaina 2014Text -
14
-
15
-
16
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma mā Ning, Jing, Jiang, Shenyi, Li, Xiaoxi, Wang, Yang, Deng, Xuhong, Zhang, Zhiqiang, He, Lijie, Wang, Daqing, Jiang, Youhong
I whakaputaina 2021Text -
17
Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer mā He, Lijie, Teng, Yuee, Jin, Bo, Zhao, Mingfang, Yu, Ping, Hu, Xuejun, Zhang, Jingdong, Li, Songbai, Gao, Yaling, Liu, Yunpeng
I whakaputaina 2010Text -
18
Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancer mā Hao, Dapeng, Wang, Guangyu, Yang, Weiwei, Gong, Jinan, Li, Xingmin, Xiao, Mingming, He, Lijie, Wang, Li, Li, Xiaobo, Di, Lijun
I whakaputaina 2019Text -
19
MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer mā Zhang, Zhiqiang, Xu, Lu, He, Lijie, Wang, Jin, Shi, Xiaonan, Li, Zhi, Shi, Sha, Hou, Kezuo, Teng, Yuee, Qu, Xiujuan
I whakaputaina 2020Text -
20